Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
Journal of the National Cancer Institute
|
September 20, 2017
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
Bernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, et al.
Plos Medicine
|
May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value
Laetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Annals of Surgery
|
October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
Jérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Cancers
|
August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore
Joseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
Immunity
|
March 17, 2016
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, et al.
Oncoimmunology
|
February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
The Journal of Pathology
|
October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.
Journal of Translational Medicine
|
October 5, 2012
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon, Franck Pagès, Francesco M Marincola, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
Journal of the National Cancer Institute
|
September 20, 2017
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
Bernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, et al.
Plos Medicine
|
May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value
Laetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Oncoimmunology
|
December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
Annals of Surgery
|
October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
Jérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Cancers
|
August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore
Joseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
Immunity
|
March 17, 2016
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, et al.
Oncoimmunology
|
February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
The Journal of Pathology
|
October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.
Journal of Translational Medicine
|
October 5, 2012
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon, Franck Pagès, Francesco M Marincola, et al.
Page
of 13